Monthly Archives: October 2013

Featured Stories

Study Finds Metal-on-Metal Hip Implants Associated with High Incidence of Pseudotumors

Yet another study is adding to concerns about the potential dangers associated with metal-on-metal hip implants. The study, published in the Journal of Bone and Joint Surgery, found that large diameter metal-on-metal total hip replacement may be associated with a substantially higher incidence of pseudotumor formation.

Read More

New Study Links Metal-on-Metal Hip Replacement Corrosion with Adverse Local Tissue Reactions

Yet another study is pointing to potential dangers posed by metal-on-metal hip implants. This time, an article published in the Journal of Arthroplasty is reporting corrosion in the head taper junction was more likely to occur in patients with 36-mm diameter metal-on-metal hip replacement, compared to those with the same ...

Read More

Estate of Kentucky Man Alleges Wrongful Death Due to Actos Bladder Cancer

National law firm, Parker Waichman LLP, just filed a lawsuit on behalf of the estate of a Kentucky man who developed bladder cancer and subsequently died, allegedly due to the use of diabetes drug, Actos. The lawsuit names Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceuticals North America, ...

Read More

New York City Council Calls for Zadroga Act to be Renewed

New York City Council Calls for Zadroga Act to be Renewed

New York City Council members are calling for the Zadroga Act, which provides compensation and medical treatment to 9/11 victims, to be renewed.

Read More

Government Penalizes 721 Hospitals for High Rates of Infections, Injuries

Medicare is reducing payments to 721 hospitals, one out of every seven hospitals in the nation, for having high rates of “hospital-acquired” conditions (HAC.

Read More

FDA Panel Takes up Metal-on-Metal Hip Implant Safety Today

The Food and Drug Administration (FDA) is convening a meeting starting today to help decide the future of metal-on-metal hip implants following high-profile recalls and mounting questions about their overall safety.

Read More

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...

Read More

Stryker Metal Hip Implant Component Recall Bad News for Makers of Metal-on-Metal Hip Replacement Devices

Stryker’s recent recall of two metal hip implant components, the Rejuvenate Modular and ABG II modular-neck hip stems, may have dealt a serious blow to one of the key arguments medical device manufacturers have made to defend their metal-on-metal hip replacements. Facing thousands of lawsuits, the makers of ...

Read More

Boston Scientific Transvaginal Mesh

Tennessee Woman Alleges Boston Scientific Transvaginal Mesh Product Caused Painful Injuries

More reports of painful injuries are being linked to transvaginal mesh. This time, a Tennessee woman has filed a lawsuit against Boston Scientific over its Advantage Transvaginal Mid-Urethral Sling System.

Read More

Canadian Warning Issued for Actos Bladder Cancer Side Effect Risk

Health Canada has become the most recent national drug regulator to issue a warning about Actos and bladder cancer. Last month, the agency warned that interim results from a 10-year-study indicated that patients taking Actos for more than a year faced an increased risk of bladder cancer. Health Canada also ...

Read More

FDA Issues Letter to Sunovian Over Exaggerated Efficacy Claims, Minimized Risk Information


The U.S. Food and Drug Administration just wrote to Sunovian Pharmaceuticals Inc. over the way in which the drug maker promoted Brovana, its respiratory medication. In its October 24th letter, the agency stated that it found Sunovian’s marketing of Brovana … Continue reading

Posted in Pharmaceuticals |

Federal Trade Commission Sues Supplement Marketer


The Federal Trade Commission (FTC) just brought a lawsuit in Arizona federal court against a marketer of dietary supplements over alleged false weight loss claims. Product marketing touts that HCG Platinum products will enable consumers to loss a lot of … Continue reading

Posted in Consumer Fraud, Defective Products, Health Concerns, Legal News, Pharmaceuticals |

Imported Spices Have Twice the Salmonella Risk of Other Imported Foods


The U.S. Food and Drug Administration (FDA) reports that, over a three-year period, almost 7 percent of imported spices were found to be contaminated with salmonella. On Wednesday the agency released a report on spice testing between 2007 and 2010.  … Continue reading

Posted in Food Poisoning, Health Concerns, Salmonella |

Following “Pay to Play” Scandal, Federal Regulator Recommends Stricter Pain Med Controls


In a policy reversal, federal regulators are recommending more stringent control over hydrocodone-based painkillers, such as Vicodin and Lortab. The painkiller medications are considered the most popular prescription drugs in the United States and are at the center of a … Continue reading

Posted in Health Concerns, Pharmaceuticals |

Do Unpublished Clinical Trials Pose Ethical Problem?


A new analysis of 585 large clinical trials registered with the government website finds that more than a quarter have never been published in scientific journals, while slightly more than three-quarters did not post results online. Dr. Christopher W. … Continue reading

Posted in Defective Medical Devices, Health Concerns, Pharmaceuticals |

Football Helmet Brand, Year of Manufacture, Does Not Matter in Concussion Risk


Headgear on the football playing field does not necessarily increase player protection from concussion, according to emerging research, according to a new report presented at the American Academy of Pediatrics (AAP) National Conference and Exhibition in Orlando. Manufacturers have touted … Continue reading

Posted in Consumer Fraud, Defective Products |

Increased Controversy Leads to Stent Language Changes


Coronary stent guidelines are changing—by just one word—following issues over insurance and regulator disputes The American College of Cardiology is removing the word “inappropriate” from its guidelines for coronary stent implantation, according to The change will become effective next … Continue reading

Posted in Defective Medical Devices |

Fukushima Nuclear Radiation Poses Serious Threat to U.S. and Canada


Nuclear radiation from Fukushima, the tsunami-damaged Japanese nuclear plant, is radiating to the west coast of the United States. The Fukushima Daiichi plant, which was built by General Electric, was damaged by a massive earthquake and tsunami that hit Japan … Continue reading

Posted in Accident, Health Concerns, Radiation Exposure Environmental Contamination, Toxic Substances |

Delays Between Post-Marketing Studies and FDA Approvals


A new study reveals that drugs cleared under an accelerated U.S. Food and Drug Administration (FDA) program do not always fully study sufficient patient demographics. In fact, of 20 new drugs that received clearance for marketing by the FDA in … Continue reading

Posted in Pharmaceuticals |

Some Chemo Drugs Associated with Serious, Deadly Skin Reactions


Some cancer medications have been associated with significant, sometimes fatal, skin reactions, new research has found. Researchers analyzed information from published literature and national databases to understand the frequency of what they described as uncommon adverse effects, in patients being … Continue reading

Posted in Health Concerns, Pharmaceuticals |

© 2005-2016 Parker Waichman LLP ®. All Rights Reserved.